News

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has updated the U.S.
Label updates include simplified twice-yearly echo monitoring for eligible CAMZYOS patients in the maintenance phase and expanded patient eligibility with reduced contraindication ...
Use of routine thoracentesis in addition to medical therapy yielded no significant benefits for adults with heart failure and ...
An international team of researchers at the University of Manchester, Baylor College of Medicine and collaborating ...
A rare case of cor triatriatum was diagnosed in a 34-year-old woman using transoesophageal echocardiography after initial ...
Whereas obesity is a common confounder when interpreting natriuretic peptide values, and the presence of atrial fibrillation has an important influence on pretest probability, other confounders are ...
Objective Clinical decision making in chronic heart failure (CHF) is based primarily on left ventricular ejection fraction (LVEF), and only secondarily on aetiology of the underlying disease. Our aim ...
Objective To characterise minimum ‘indicative’ prevalences and mortality data for all forms of PHT in a selected population with an elevated estimated pulmonary artery systolic pressure (ePASP) on ...
Parameters for LGE study were as follows: echo time 1.25 ms, repetition time 4.1 ms ... mL/m 2 79.3±30.0 LV end‐systolic volume index, mL/m 2 31.2±30.5 LV ejection fraction, % 65.6±16.9 Late ...
Exo (pronounced "echo"), the leader in AI-powered ... GLS is a game-changing indicator for myocardial dysfunction earlier than ejection fraction (EF) and before symptoms appear. "This clearance ...
--(BUSINESS WIRE)--Exo (pronounced “echo”), the leader in AI-powered ... indicator for myocardial dysfunction earlier than ejection fraction (EF) and before symptoms appear.
In an eight-game NBA slate on Sunday, the final one of the day was the Houston Rockets facing the Phoenix Suns. The Rockets took a comfortable 78-49 lead into halftime in a lopsided first half.